Dr Ana-Mishel (AM) Spiroski and Ziad Mallat
Dec 18, 2025, 23:22
Dr Ana-Mishel (AM) Spiroski Shares Ziad Mallat’s Article: Translating Nobel Prize-Winning Treg Cell Science Into Cardiovascular Therapy
Dr Ana-Mishel (AM) Spiroski, Cardiovascular TA Lead, Age-Related Diseases TA Lead, Group Leader, In Vivo Pharmacology at Evotec, quoted Ziad Mallat’s post on LinkedIn:
“This is one of the most exciting areas in cardiovascular drug development. A fantastic comment by Professor Zallat Cambridge Cardiovascular on the potential of immune tolerance in cardiovascular therapeutics.”
Quoting Ziad Mallat’s post:
“Here’s the full PDF of the comment published in Nature Cardiovascular Reserach. Translating Nobel Prize-winning Treg cell science into cardiovascular therapy.”
Read full article here.
Follow the latest in Hemostasis Today.
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?